Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 55

1.

Notes from the Field: Intestinal Colonization and Possible Iatrogenic Botulism in Mouse Bioassay-Negative Serum Specimens - Los Angeles County, California, November 2017.

Halai UA, Terashita D, Kim M, Green N, Kalb SR, Chatham-Stephens K, Balter S.

MMWR Morb Mortal Wkly Rep. 2018 Nov 2;67(43):1221-1222. doi: 10.15585/mmwr.mm6743a6. No abstract available.

2.

Characterization of Hemagglutinin Negative Botulinum Progenitor Toxins.

Kalb SR, Baudys J, Smith TJ, Smith LA, Barr JR.

Toxins (Basel). 2017 Jun 15;9(6). pii: E193. doi: 10.3390/toxins9060193.

3.

Further optimization of peptide substrate enhanced assay performance for BoNT/A detection by MALDI-TOF mass spectrometry.

Wang D, Baudys J, Hoyt KM, Barr JR, Kalb SR.

Anal Bioanal Chem. 2017 Aug;409(20):4779-4786. doi: 10.1007/s00216-017-0421-8. Epub 2017 Jun 2.

4.

Engineering Botulinum Neurotoxin C1 as a Molecular Vehicle for Intra-Neuronal Drug Delivery.

Vazquez-Cintron EJ, Beske PH, Tenezaca L, Tran BQ, Oyler JM, Glotfelty EJ, Angeles CA, Syngkon A, Mukherjee J, Kalb SR, Band PA, McNutt PM, Shoemaker CB, Ichtchenko K.

Sci Rep. 2017 Feb 21;7:42923. doi: 10.1038/srep42923.

5.

Historical Perspectives and Guidelines for Botulinum Neurotoxin Subtype Nomenclature.

Peck MW, Smith TJ, Anniballi F, Austin JW, Bano L, Bradshaw M, Cuervo P, Cheng LW, Derman Y, Dorner BG, Fisher A, Hill KK, Kalb SR, Korkeala H, Lindström M, Lista F, Lúquez C, Mazuet C, Pirazzini M, Popoff MR, Rossetto O, Rummel A, Sesardic D, Singh BR, Stringer SC.

Toxins (Basel). 2017 Jan 18;9(1). pii: E38. doi: 10.3390/toxins9010038. Review.

6.

Notes from the Field: Botulism Outbreak from Drinking Prison-Made Illicit Alcohol in a Federal Correctional Facility - Mississippi, June 2016.

McCrickard L, Marlow M, Self JL, Watkins LF, Chatham-Stephens K, Anderson J, Hand S, Taylor K, Hanson J, Patrick K, Luquez C, Dykes J, Kalb SR, Hoyt K, Barr JR, Crawford T, Chambers A, Douthit B, Cox R, Craig M, Spurzem J, Doherty J, Allswede M, Byers P, Dobbs T.

MMWR Morb Mortal Wkly Rep. 2017 Jan 6;65(52):1491-1492. doi: 10.15585/mmwr.mm6552a8. No abstract available.

7.

Purification and Characterization of Botulinum Neurotoxin FA from a Genetically Modified Clostridium botulinum Strain.

Pellett S, Tepp WH, Bradshaw M, Kalb SR, Dykes JK, Lin G, Nawrocki EM, Pier CL, Barr JR, Maslanka SE, Johnson EA.

mSphere. 2016 Feb 24;1(1). pii: e00100-15. doi: 10.1128/mSphere.00100-15. eCollection 2016 Jan-Feb.

8.

Improved Sensitivity for the Qualitative and Quantitative Analysis of Active Ricin by MALDI-TOF Mass Spectrometry.

Wang D, Baudys J, Barr JR, Kalb SR.

Anal Chem. 2016 Jul 5;88(13):6867-72. doi: 10.1021/acs.analchem.6b01486. Epub 2016 Jun 15.

9.

Recommended Mass Spectrometry-Based Strategies to Identify Ricin-Containing Samples.

Kalb SR, Schieltz DM, Becher F, Astot C, Fredriksson SÅ, Barr JR.

Toxins (Basel). 2015 Nov 25;7(12):4881-94. doi: 10.3390/toxins7124854.

10.

Detection of the HA-33 protein in botulinum neurotoxin type G complex by mass spectrometry.

Kalb SR, Baudys J, Barr JR.

BMC Microbiol. 2015 Oct 23;15:227. doi: 10.1186/s12866-015-0567-5.

11.

Mass Spectrometric Detection of Bacterial Protein Toxins and Their Enzymatic Activity.

Kalb SR, Boyer AE, Barr JR.

Toxins (Basel). 2015 Aug 31;7(9):3497-511. doi: 10.3390/toxins7093497. Review.

12.

A Novel Botulinum Neurotoxin, Previously Reported as Serotype H, Has a Hybrid-Like Structure With Regions of Similarity to the Structures of Serotypes A and F and Is Neutralized With Serotype A Antitoxin.

Maslanka SE, Lúquez C, Dykes JK, Tepp WH, Pier CL, Pellett S, Raphael BH, Kalb SR, Barr JR, Rao A, Johnson EA.

J Infect Dis. 2016 Feb 1;213(3):379-85. doi: 10.1093/infdis/jiv327. Epub 2015 Jun 10.

13.

Recommended mass spectrometry-based strategies to identify botulinum neurotoxin-containing samples.

Kalb SR, Baudys J, Wang D, Barr JR.

Toxins (Basel). 2015 May 19;7(5):1765-78. doi: 10.3390/toxins7051765.

14.

Enhanced detection of type C botulinum neurotoxin by the Endopep-MS assay through optimization of peptide substrates.

Wang D, Krilich J, Baudys J, Barr JR, Kalb SR.

Bioorg Med Chem. 2015 Jul 1;23(13):3667-73. doi: 10.1016/j.bmc.2015.04.012. Epub 2015 Apr 10.

15.

Functional characterization of botulinum neurotoxin serotype H as a hybrid of known serotypes F and A (BoNT F/A).

Kalb SR, Baudys J, Raphael BH, Dykes JK, Lúquez C, Maslanka SE, Barr JR.

Anal Chem. 2015 Apr 7;87(7):3911-7. doi: 10.1021/ac504716v. Epub 2015 Mar 17.

16.

Isolation and functional characterization of the novel Clostridium botulinum neurotoxin A8 subtype.

Kull S, Schulz KM, Weisemann J, Kirchner S, Schreiber T, Bollenbach A, Dabrowski PW, Nitsche A, Kalb SR, Dorner MB, Barr JR, Rummel A, Dorner BG.

PLoS One. 2015 Feb 6;10(2):e0116381. doi: 10.1371/journal.pone.0116381. eCollection 2015.

17.

Detection of Botulinum Toxins A, B, E, and F in Foods by Endopep-MS.

Kalb SR, Krilich JC, Dykes JK, Lúquez C, Maslanka SE, Barr JR.

J Agric Food Chem. 2015 Feb 4;63(4):1133-1141. doi: 10.1021/jf505482b. Epub 2015 Jan 22.

18.

A two-stage multiplex method for quantitative analysis of botulinum neurotoxins type A, B, E, and F by MALDI-TOF mass spectrometry.

Wang D, Baudys J, Krilich J, Smith TJ, Barr JR, Kalb SR.

Anal Chem. 2014 Nov 4;86(21):10847-54. doi: 10.1021/ac502948v. Epub 2014 Oct 20.

19.

Optimization of peptide substrates for botulinum neurotoxin E improves detection sensitivity in the Endopep-MS assay.

Wang D, Krilich J, Baudys J, Barr JR, Kalb SR.

Anal Biochem. 2015 Jan 1;468:15-21. doi: 10.1016/j.ab.2014.08.026. Epub 2014 Sep 16.

20.

Validation of the Endopep-MS method for qualitative detection of active botulinum neurotoxins in human and chicken serum.

Björnstad K, Tevell Åberg A, Kalb SR, Wang D, Barr JR, Bondesson U, Hedeland M.

Anal Bioanal Chem. 2014 Nov;406(28):7149-61. doi: 10.1007/s00216-014-8170-4. Epub 2014 Sep 17.

Supplemental Content

Loading ...
Support Center